IDEXX Labs (IDXX) Misses Q4 EPS Views; Nudges FY15 Outlook Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
IDEXX Laboratories (IDXX) PT Raised to $160 at Piper Jaffray Following In-Line Q4; 'Neutral' Rating Maintained
February 2, 2015 7:23 AM ESTPiper Jaffray analyst Kevin Ellich raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $160.00 (from $129.00) following mostly in-line Q4 results. The firm maintained a Neutral rating.
Ellich commented, "Q4 results were relatively in line with Street expectations and IDXX increased FY15 normalized... More
